Sripal Bangalore at [NYU Langone Medical Center]

Sripal Bangalore, MD

  • Specialties: Interventional Cardiology, Cardiology
  • Languages: English, Hindi
  • Phone: 212-263-5656

About Me

Conditions and Treatments

renal artery stenosis, high blood pressure disorder, mitral regurgitation (MR), peripheral vascular disease (PVD), peripheral vascular disease (PVD), aortic valve stenosis, mitral valve stenosis, carotid stenosis, heart attack, claudication, carotid artery disease, coronary heart disease, heart disease, mitral valve disease, aortic valve disease, acute coronary syndrome, atrial septal defect (ASD), pulmonary stenosis, heart valve diseases, arterial occlusive disease, aortic valve insufficiency, critical limb ischemia, cardiac catheterization
Show More Conditions

Credentials

Positions
  • Associate Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Interventional Cardiology), 2009
  • American Board of Internal Medicine (Cardiovascular Disease), 2008
Education and Training
  • Fellowship, Peter Bent Brigham Hospital, Interventional Card., 2010
  • Fellowship, St. Luke's-Roosevelt Hospital Center, Cardiovascular Med, 2008
  • MD from Bangalore University, 2000
Departments

Locations and Appointments

71 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Agewell
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Essential
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Essential
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthSmart (WTC)
  • Healthfirst
  • Healthfirst Essential
  • Hotel Trades
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare Core and Charter
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Village Caremax
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Cardiac Catheterization Associates

550 1st Avenue, 14th Floor
New York, NY 10016

Contact

Phone: 212-263-5656

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Dr. Bangalore is the PI of a multicenter, international, randomized controlled trial conducted to define the role of an invasive approach in patients with stable ischemic heart disease and substantial ischemia and chronic kidney disease (eGFR <30 or on dialysis). Patients with advanced CKD and moderate to severe ischemia on stress testing will be randomized to INV strategy of cath with optimal revascularization along with optimal medical therapy or to a CON strategy of optimal medical therapy alone with cath reserved for OMT failure. http://clinicaltrials.gov/ct2/show/NCT01985360

Publications

  • In reply [Letter]

    Bangalore, S; Maron, D J; Hochman, J S
    JAMA. 2016.

  • Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials

    Bangalore, Sripal; Fakheri, Robert; Toklu, Bora; Messerli, Franz H
    British medical journal. BMJ (Clinical research ed.). 2016 Feb 11. 352: i438-i438 i438

  • In Reply-The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality [Letter]

    Bangalore, Sripal; Fakheri, Robert; Toklu, Bora; Messerli, Franz H
    Mayo Clinic proceedings. 2016 Jul. 91 (7): 972-975

Read All Publications (356)